CD8+ T cell supernatants of HIV type 1-infected individuals have opposite effects on long terminal repeat-mediated transcription in T cells and monocytes

AIDS Research and Human Retroviruses

Volumn 13, Issue 1, 1997, Pages 71-77

  Copeland, Karen F T ^a   Leith, Jonathan G ^a   McKay, Paula J ^a   Rosenthal, Kenneth L ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0031021622     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.71     Document Type: Article

References (41)

1. Walker CM, Moody DJ, Stiles DP, and Levy JA: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-1566.
2. Brinchmann JE, Gaudernack G, and Vartdal F: CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells: Evidence for a soluble inhibitor. J Immunol 1990;144:2961-2966.
3. Walker CM and Levy JA; A diffusable lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 1989;66:628-630.
4. Tsubota H, Lord CJ, Watkins DJ, Morimoto C, and Letvin NL: A cytotoxic T lymphocyte inhibits acquired immunodeficiency virus replication in peripheral blood lymphocytes. J Exp Med 1989; 169:1421-1434.
5. Bagasra O and Pomerantz RJ: The role of CD8-positive lymphocytes in the control of HIV-1 infection of peripheral blood mononuclear cells. Immunol Lett 1993;35:83-92.
6. + cells from HIV infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol 1991;137:420-428.
7. Powell JD, Bednarik DP, Folks TM, Jehuda-Cohen T, Villinger F, Sell KW, and Ansari AA: Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from nonhuman primates. Clin Exp Immunol 1993;91:473-481.
8. Ennen J, Findekelle H, Dittmar MT, Norley S, Ernst M, and Kurth R: CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc Natl Acad Sci USA 1994;91:7207-7211.
9. Husch B, Eibl MM, and Mannhalter JW: CD3, CD8 double-positive cells from HIV-1-infected chimpanzees show group-specific inhibition of HIV-1 replication. AIDS Res Hum Retroviruses 1993;9:405-413.
10. + cells from infected and uninfected chimpanzees. Cell Immunol 1991;132:246-255.
11. + cells from nonhuman primates. J AIDS 1994;7:438-446.
12. Chen C-H, Weinhold KJ, Bartlett JA, Bolognesi DP, and Greenberg M: CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retroviruses 1993;9:1079-1086.
13. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 1995;92:2308-2312.
14. + T-cells is not lentivirus specific. AIDS Res Hum Retroviruses 1995;11:1321-1326.
15. + T-cells is dependant on the NFAT-1 element. AIDS Res Hum Retroviruses 1996;12:143-148.
16. + T cells. Science 1995;270:1811-1815.
17. Baier M, Werner A, Bannert N, Metzner K, Kurth R: HIV suppression by interleukin-16. Nature (London) 1995;378:563.
18. Gartner S, Markovits P, Markovits DM, Kaplan MH, Gallo RC, and Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986;233:215-219.
19. Gendelman HE, Orenstein JM, Baca LM, Weiser B, Burgers H, Kalter DC, and Meltzer MS: The macrophage in the persistence and pathogenesis of HIV infection. AIDS 1989;3:475-495.
20. Schmidtmayerova H, Nottet HSL, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, and Sherry B: Human immunodeficiency virus type 1 infection alters chemokine β peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 1996;93:700-704.
21. Felber BK and Pavlakis GN: A quantitative bioassay for HIV-1 based on trans-activation. Science 1988;239:184-187.
22. Schwartz S, Felber BK, Fenyö EM, and Pavlakis GN: Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines. Proc Natl Acad Sci USA 1989;86:7200-7203.
23. Folks TM, Justement J, Kinter A, Dinarello CA, and Fauci AS: Cytokine-induced expression of HIV-1 in a chronically infected promonocytic cell line. Science 1987;238:800-802.
24. Berkhout B, Silverman RH, and Jeang K-T: Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 1989;59:273-282.
25. Peterlin M, Luciw PA, Barr JP, and Walker MD: Elevated levels of mRNA can account for the transactivation of human immunodeficiency virus (HIV). Proc Natl Acad Sci USA 1986;83:9734-9738.
26. Queen C and Baltimore D: Immunoglobulin gene transcription is activated by downstream sequence elements. Cell 1983;33:741-748.
27. Herbomel P, Bourachof B, and Yaniv M: Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 1984;39:653-661.
28. Stevenson M and Gendelman HE: Cellular and viral determinants that regulate HIV-1 infection in macrophages. J Leuk Biol 1994;56:278-288.
29. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Hasse AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
30. Oppenheim JJ, Zachariae COC, Mukaida N, and Matsushima K: Properties of the novel proinflammatory supergene: "Interkrine" cytokine family. Annu Rev Immunol 1991;9:617-648.
31. Poli G and Fauci AS: Cytokine modulation of HIV expression. Semin Immunol 1993;5:165-173.
32. Koyanagi Y, O'Brien WA, Zhao JQ, Golde DW, Gasson JC, and Chen ISY: Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988;241:1673-1675.
33. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, Skillman D, and Meltzer MS: Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 1990;167:1428-1441.
34. Biswas P, Poli G, Kinter AL, Justement JS, Stanley SK, Maury WJ, Bressler P, Orenstein JM, and Fauci AS: Interferon γ induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J Exp Med 1992;176:739-750.
35. Yamada O, Hattori N, Kurimura T, Kita M, and Kishida T: Inhibition of growth of HIV by human natural infection in vitro. AIDS Res Hum Retroviruses 1988;4:287-294.
36. Hammer SM, Gillis JM, Groopman JE, and Rose RM: In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon. Proc Natl Acad Sci USA 1986;83:8734-8738.
37. Hartshorn KL, Neumeyer D, Vogt MW, Schooley RT, and Hirsch MS: Activity of interferons alpha, beta and gamma against human immunodeficiency virus replication in vitro. AIDS Res Hum Retroviruses 1900;3:125.
38. Vicenzi E and Poli G: Regulation of HIV expression by viral genes and cytokines. J Leuk Biol 1994;56:328-334.
39. Schuitemaker H, Kootstra NA, De Goede REY, De Wolf F, Miedema F, and Tersmette M: Monocytotropic human immunodeficiency virus 1 (HIV-1) variants detectable in all stages of HIV infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 1991;65:356-363.
40. + T cells correlates with CD4 counts and clinical stage of disease. Clin Exp Immunol 1994;97:68-75.
41. Landay AL, Mackewicz CE, and Levy JA: An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol 1993;69:106-116.